- Home
- REPL vs NBBK Comparison
REPL vs NBBK Comparison
Compare REPL & NBBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- NBBK
- Stock Information
- Founded
- REPL 2015
- NBBK 1892
- Country
- REPL United States
- NBBK United States
- Employees
- REPL N/A
- NBBK N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- NBBK
- Sector
- REPL Health Care
- NBBK
- Exchange
- REPL Nasdaq
- NBBK Nasdaq
- Market Cap
- REPL 649.1M
- NBBK 661.3M
- IPO Year
- REPL 2018
- NBBK N/A
- Fundamental
- Price
- REPL $9.63
- NBBK $16.87
- Analyst Decision
- REPL Strong Buy
- NBBK Buy
- Analyst Count
- REPL 7
- NBBK 1
- Target Price
- REPL $20.29
- NBBK $22.00
- AVG Volume (30 Days)
- REPL 1.7M
- NBBK 132.1K
- Earning Date
- REPL 05-22-2025
- NBBK 07-23-2025
- Dividend Yield
- REPL N/A
- NBBK N/A
- EPS Growth
- REPL N/A
- NBBK 421.39
- EPS
- REPL N/A
- NBBK 1.18
- Revenue
- REPL N/A
- NBBK $169,131,000.00
- Revenue This Year
- REPL N/A
- NBBK N/A
- Revenue Next Year
- REPL N/A
- NBBK N/A
- P/E Ratio
- REPL N/A
- NBBK $14.26
- Revenue Growth
- REPL N/A
- NBBK 27.71
- 52 Week Low
- REPL $4.93
- NBBK $14.20
- 52 Week High
- REPL $17.00
- NBBK $21.05
- Technical
- Relative Strength Index (RSI)
- REPL 58.72
- NBBK 44.82
- Support Level
- REPL $8.25
- NBBK $16.54
- Resistance Level
- REPL $10.16
- NBBK $17.00
- Average True Range (ATR)
- REPL 0.92
- NBBK 0.28
- MACD
- REPL 0.21
- NBBK -0.06
- Stochastic Oscillator
- REPL 84.04
- NBBK 25.98
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About NBBK NB Bancorp Inc.
NB Bancorp Inc operates as the holding company of Needham Bank. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate and multifamily loans, one- to four-family residential real estate loans, construction and land development loans, commercial and industrial loans, and consumer loans.